Related Experiment Video
Updated: Jul 3, 2026

Channelrhodopsin2 Mediated Stimulation of Synaptic Potentials at Drosophila Neuromuscular Junctions
Published on: March 16, 2009
New light on the "old" chloride channel blocker DIDS
1Department of Pharmacology, University of California, Davis, 451 Health Sciences Drive, Davis, California 95616, USA. hwulff@ucdavis.edu
4,4'-Diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS) degrades in water into more potent inhibitors of chloride channels. These DIDS polymers, particularly tetra- and pentamers, show enhanced efficacy in blocking bacterial and mammalian chloride transport proteins.
Area of Science:
- Biochemistry
- Molecular Biology
- Membrane Transport
Background:
- 4,4 '-Diisothiocyanatostilbene-2,2 '-disulfonic acid (DIDS) is a long-standing inhibitor of anion transporters.
- The precise mechanism and potency of DIDS and its derivatives in inhibiting specific ion channels remain areas of active research.
Purpose of the Study:
- To investigate the degradation products of DIDS in aqueous solution.
- To evaluate the inhibitory potency of DIDS multimers on bacterial and mammalian chloride channels.
- To explore the potential mechanism of action of DIDS polymers as channel blockers.
Main Methods:
- Hydrolysis of DIDS in aqueous solution.
- Characterization of DIDS degradation products (polymers).
- Inhibition assays using bacterial ClC-ec1 Cl(-)/H(+) exchanger and mammalian ClC-Ka chloride channel.
Main Results:
- DIDS hydrolyzes and multimerizes into di-, tri-, tetra-, and pentameric polythioureas.
- These DIDS polymers exhibit significantly higher potency (3-200 times) in inhibiting ClC-ec1 and ClC-Ka compared to DIDS itself.
- The tetra- and pentameric forms show potential as tethered blockers for dimeric CLC proteins.
Conclusions:
- DIDS degradation products are more potent inhibitors of anion transport than the parent compound.
- DIDS polymers represent a new class of potent inhibitors for CLC family transporters.
- The multimeric structure of DIDS derivatives may enable novel blocking mechanisms in dimeric channel proteins.
More Related Videos
08:31FM Dye Cycling at the Synapse: Comparing High Potassium Depolarization, Electrical and Channelrhodopsin Stimulation
Published on: May 24, 2018
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics